A better surface for better cell culture

SENCE™ is a range of cell culture well plates coated with a biomimetic, animal-free surface, designed to enhance existing workflows.

  • Xeno-free
  • Quality controlled
  • Batch-consistent
A transparent green plastic tray with 72 round wells arranged in a grid pattern, used for laboratory sample testing.Image of a Cell
Problem

Cells in the lab don’t behave like cells in the body

However, medicines and therapies rely on experiments with human cells, often cultured in plastic environments.

Advanced therapies need next-generation culture environments. This is where our SENCE™ platform comes in.

Lab cell culture experiments suffer on several key fronts:

  • Environments lack physiological accuracy, limiting predictive power

  • Cells behave differently in vitro than they do in the human body

  • Research relies heavily on animal cells, reducing translational relevance

PLASTIC VS SENCE™

Plastic introduces variability. SENCE™ removes it. Same plate. Same workflow. Different surface.

Compare standard tissue-culture plastic and protein coatings with a defined, synthetic SENCE™ surface, designed to reduce variability and improve reproducibility. No new workflow. Just a better surface.

Standard 96 well plate

SENCE™ 96 well plate

Conventional plastic + coatings

  • Fixed, non-physiological stiffness

  • Variable protein presentation

  • Coatings can degrade or detach

  • Hidden assay variability

  • Surface effects are hard to control

SENCE™ defined surface

Cross-sectional illustration of cells growing adhered to a petri dish surface containing culture medium.
  • Tissue-relevant, defined stiffness

  • Stable, covalently tethered ECM

  • Independent control of mechanics + coating

  • Reduced variability across experiments

  • Defined, QC-controlled surface

Transparent 96-well microplate used for laboratory sample storage and analysis.
Designed for real-world workflows

The SENCE™ Surface

We design, build and optimise cell culture envionments to 'feel' to cells like specific areas of the body. We sell ready to use products or partner to create novel environments

Replace plastic

Our biometric coating produces pure cell populations, exactly to your needs, without any unwanted 'extras'.

Reduce variability

Cells keep working properly for much longer on standard plates, extending research windows significantly.

Scale easily

A technology which works and scales across workflows, from plates, flasks and beads, to bioreactors.

SENCE™ has already been tuned to many specific cell culture niches which are ready for purchase through our Early Access Program

A few examples include:

The core technology platform material is precisely tuned, together with media conditions, to create complete cell culture environments that replicate diverse human tissues.

Microscopic 3D visualization of lymphatic cells within a fibrous, translucent network in purple and pink tones.
01

Lymph node environment

We are developing a base environment that captures the structural and mechanical features of the lymph node. This will provide the foundation for exploring immune cell behaviour and for future tuning into specific applications, such as T cell culture.

Make an order request
Liver environment
02

Liver environment

A developing niche designed to reflect the mechanobiology of liver tissue. Our aim is to create a platform that supports studies of liver cell development and function, forming the groundwork for future tuning towards hepatocyte, cholangiocyte, and metabolic applications.

Make an order request
Microscopic image of neurons
03

Brain environment

An environment that reflects the physical and structural cues of brain tissue. This foundation is intended to support investigations of neural and glial biology, with the potential to be tuned for applications in ageing, repair, and disease modelling.

Make an order request
3D representation of joint tissue with spherical molecules embedded in layered bone and cartilage structure.
04

Joint environment

A pilot environment to model the unique stiffness and extracellular structure of cartilage. It is designed to provide a baseline setting for maintaining chondrocyte identity and mesenchymal cell behaviour, forming the starting point for future tuning toward joint regeneration and arthritis research.

Make an order request
3D illustration of human cells with visible nuclei and a soft, fluid-like background.
05

Your environment

With SENCE™, you can work with us to design and build an environment tailored to your research. Together, we’ll tune the mechanics and biochemistry to create the right conditions for your specific cells, enabling a true-to-life model of your choice.

Make an order request

The opportunity to create a comprehensive array of products

Driven by customer needs, it will be possible within each distinct environment to create specific applications. These will be ready-to-use products and will not require further tuning by customers in their own labs.

Launching 2026

Regulatory T cell enrichment (Treg-SENCE™)

A tuned lymph node environment designed to improve the expansion and purity of regulatory T cells. Developed to support research and manufacturing workflows where Tregs play a critical role in immune modulation.

Launching 2027

iPSC-derived T cells (T-SENCE™)

A next-generation immune environment tailored for generating functional T cells from iPSCs. Intended to accelerate discovery and translational research in immunotherapies and beyond.

Seeking partners

Cartilage growth & rejuvenation (Cart-SENCE™)

A cartilage-mimetic environment to maintain chondrocyte phenotype and support regenerative growth. Being developed for disease modelling and preclinical research in joint repair.

Seeking partners

Cholangiocyte differentiation & bile duct disease (iHEP-SENCE™ / Hep-SCREEN™)

An engineered liver environment for guiding iPSCs into cholangiocytes, supporting studies of bile duct development and pathology. Intended as a platform for disease models and drug discovery in cholangiopathies.

Our Cell Culture Platform

Ready-to-use cell culture surfaces that reduce variability

Standard plates, coverslips and inserts coated with a synthetic, xeno-free hydrogel, designed to improve reproducibility without changing your workflow.

Start an order request
What you get:
  • Reduce variability

    Tailored environments designed for your specific cell type and application.

  • Controlled Microenvironments

    Precise regulation of key variables to reduce experimental variability.

  • Scalable Platform Architecture

    Move from research to production without redesigning your setup.

Why teams choose Stembond

Increased
consistency of results

Closer to real 
biological conditions

Pre-configured setups for immediate use

Enabling future applications

Image of a Cell
About StemBond

We believe cells should be grown in environments that reflect real biology, not rigid plastic or variable coatings.

StemBond develops synthetic, ready-to-use surfaces that give cells a more realistic environment while improving reproducibility in standard workflows.

Our Team

Meet the team

Andrew combines physics, stem cell research, and entrepreneurial leadership to drive StemBond’s vision. He leads strategy, fundraising, and operations, building the SENCE™ platform into transformative cell culture products.

Dr Andrew Hodgson
Co-Founder & CEO

Kevin is a Cambridge University academic and co-inventor of StemBond’s core technology. He contributes world-leading expertise in stem cell biology and biophysics to platform innovation and strategy.

Prof Kevin Chalut
Co-Founder & Scientific Advisor

Robert is a biotech veteran and co-founder of PCT (now Hitachi Chemical). He brings decades of expertise in cell and gene therapy innovation, commercialisation, and governance.

Dr Robert Preti
Board Chair & Advisor

Miguel is a physician-executive with global leadership experience in biotech, cell therapy, and venture investment. He provides strategic, clinical, and regulatory expertise to guide StemBond’s mission.

Dr Miguel Forte
Board Member & Advisor

Rob brings extensive commercial experience in life sciences tools. He builds partnerships, customer pipelines, and investor networks, positioning StemBond’s SENCE™ platform for broad adoption and long-term growth.

Dr Rob Marchmont
CCO

Jason is Managing Partner at Start Codon, a biotech leader and investor with a PhD in Medicine from Cambridge, specialising in oncology, innovation, and early-stage life sciences.

Dr Jason Mellad
Investor Director

Deputy Head of Ventures at Cambridge Enterprise, University of Cambridge. Amanda has a PhD in molecular endocrinology from Cambridge, followed by post-doctoral research positions in both academia and industry.

Dr Amanda Wooding
Investor Director